Stock listing
Dogwood Therapeutics, Inc.
Selected listing: DWTX · NASDAQ · USD · US
Dogwood Therapeutics, Inc. (NASDAQ:DWTX), Health Technology. Latest release Oct 6, 2026: Dogwood to Participate in the 2026 Maxim Growth Summit.
- Ticker
- NASDAQ:DWTX
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Dogwood Therapeutics, Inc.
The company is focused on developing innovative therapeutic solutions. As a publicly traded entity, it is listed on the relevant stock exchanges in America.
Latest news from Dogwood Therapeutics, Inc.
Dogwood to Participate in the 2026 Maxim Growth Summit
October 6, 2026
Dogwood Announces Completion of Enrollment in Ongoing Halneuron® Phase 2b Trial
September 14, 2026
Dogwood to Host Virtual KOL Event to Discuss Halneuron® for the Treatment of Chemotherapy Induced Neuropathic Pain on September 1, 2026
August 17, 2026
Dogwood Therapeutics Announces Second Quarter 2026 Financial Results
August 13, 2026
Dogwood Enrolls First 200 Patients in Ongoing Halneuron® Phase 2b Chemotherapy Induced Neuropathy Trial; Top-line Data Expected in Fall 2026
July 20, 2026
Events
Research Dogwood Therapeutics, Inc.
Dogwood Therapeutics, Inc. company profile
View the public company page for Dogwood Therapeutics, Inc. on 6ix.
Dogwood Therapeutics, Inc. news
Read company news and market updates connected to Dogwood Therapeutics, Inc..
Dogwood Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Dogwood Therapeutics, Inc..